Deepak Chemtex Ltd

Key decisions

• Approved Directors' Report along with MD&A for the year ended 31 March 2026 for submission to shareholders.
• Fixed 29th AGM date as 21 September 2026, via VC/OAVM.

Saurabh Deepak Arora — CMD Re-appointment

• Re-appointment as Chairman and Managing Director for 3 years.
• Effective from 28 July 2026 to 27 July 2029, liable to retirement by rotation.
• Subject to approval of the members.
• Brief profile: Board since incorporation; 26 years in chemical/colorant industry; BSc Ruia College; oversees overall management.
• Spouse of Trishla Baid Arora; son-in-law of Narendra Kumar Baid.
• Not debarred from holding office by SEBI or other authorities.

Trishla Baid Arora — WTD Re-appointment

• Re-appointment as Whole-time Director for 3 years.
• Effective from 28 July 2026 to 27 July 2029, liable to retirement by rotation.
• Subject to approval of the members.
• Board member since January 2014; BA 1998; 21 years in accounts/finance.
• Currently heads Accounts and Finance function.
• Spouse of Saurabh Deepak Arora; daughter of Narendra Kumar Baid.

Demat/rematerialisation status

• RTA confirmed Regulation 74(5) not applicable as entire shareholding is in demat form.
• No requests for rematerialisation/dematerialisation were received during quarter ended 30 June 2026.

Board outcome

• 📍 Board approved audited standalone and consolidated results for FY26 and H2 FY26.
• 📍 Statutory auditors issued unmodified opinions on the half-year and full-year results.
• 🗓️ Board meeting was held on May 29, 2026, and concluded at 4:00 p.m.

Standalone financials

• 📊 Revenue from operations rose to ₹5,349.61 lakh in FY26 from ₹6,799.68 lakh.
• 📊 Total income fell to ₹5,648.61 lakh from ₹7,050.35 lakh.
• 📊 PBT declined to ₹893.00 lakh from ₹1,376.68 lakh.
• 📊 PAT fell to ₹659.26 lakh from ₹1,006.85 lakh.
• 📊 FY26 EPS was ₹5.97, versus ₹9.27 in FY25.
• 📊 Raw material cost was ₹3,240.05 lakh; employee cost was ₹384.01 lakh.
• 📊 Cash and bank balances ended at ₹323.74 lakh, versus ₹485.50 lakh last year.

Consolidated financials

• 📊 Revenue from operations rose to ₹6,763.87 lakh in FY26 from ₹7,944.51 lakh.
• 📊 Total income declined to ₹7,062.88 lakh from ₹8,185.37 lakh.
• 📊 PBT fell to ₹1,160.09 lakh from ₹1,672.33 lakh.
• 📊 PAT attributable to shareholders was ₹824.67 lakh, versus ₹1,235.83 lakh.
• 📊 FY26 consolidated EPS was ₹7.80, versus ₹11.69 in FY25.
• 📊 Inventory increased to ₹2,053.58 lakh from ₹1,120.86 lakh.
• 📊 Trade receivables were ₹1,638.84 lakh, versus ₹2,016.41 lakh last year.

Cash flow and balance sheet

• 📊 Standalone operating cash flow was ₹133.22 lakh in FY26, versus ₹1,078.83 lakh.
• 📊 Consolidated operating cash flow was ₹614.65 lakh, versus ₹296.04 lakh.
• 🧱 Standalone capex on PPE and intangibles was ₹301.37 lakh in FY26.
• 🧱 Consolidated capex on fixed assets was ₹1,202.34 lakh in FY26.
• 📊 Standalone long-term loans and advances rose to ₹2,250.27 lakh from ₹1,853.72 lakh.
• 📊 Consolidated property, plant and equipment rose to ₹1,725.19 lakh from ₹1,325.23 lakh.

Operations and structure

• 🗒️ The company reported a single operating segment in standalone results.
• 🗒️ Consolidated results included Deepak Chemtex, DCPL Speciality Chemicals, South West Chemicals Corporation, and Atlas Tints.
• 🗒️ Consolidated results included a foreign subsidiary audited by its respective auditor.

Risks and notes

• ⚠️ Management said the new labour codes had no material impact so far.
• ⚠️ The company continues monitoring final Central and State rules on labour codes.